Spondyloarthritis
📧 Sign up to get email alerts when something new happens for Spondyloarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-22Clinical Trial Update: Ecological Momentary Assessment and Physical Activity in Patients With Inflammatory Rheumatic Diseases
This update reports the completion of a study examining ecological momentary assessment and physical activity in patients with inflammatory …
-
CLINICAL_TRIALS trial_result · 2026-04-08Clinical Trial Update: Sub-cutaneous Infliximab in Inflammatory Rheumatic Disease
Clinical trial update indicating a completed study of sub-cutaneous infliximab for inflammatory rheumatic diseases, including rheumatoid art…
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: SarS-Cov-2 Viral Infection (COVID-19) in Patients With Chronic Inflammatory Rheumatism [NA]
ClinicalTrials.gov entry reports termination of a study evaluating SARS-CoV-2 infection in patients with chronic inflammatory rheumatism, in…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Move Your Spondyl " Better Live Its Rheumatism With the Physical Activity " [NA]
A clinical trial investigating a physical activity program for individuals with spondyloarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2026-01-27Clinical Trial Update: Dynamic and Static Balance and the Speed of Reaction in the Elderly [NA]
A clinical trial update for NCT05442944 reports that the study on dynamic and static balance and reaction speed in the elderly has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-01-15Clinical Trial Update: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital
The study evaluated switching patients from original infliximab to its biosimilar in daily practice at Cochin Hospital, across rheumatoid ar…
-
CLINICAL_TRIALS trial_result · 2025-12-24Clinical Trial Update: A Study of Novel Immune Modulating Biomarkers in Patients With Spondyloarthritis With Axial Involvement
This entry notes the completion of a clinical trial evaluating novel immune-modulating biomarkers in patients with axial spondyloarthritis.
-
CLINICAL_TRIALS trial_result · 2025-12-03Clinical Trial Update: Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases [Phase 4]
Phase 4 clinical trial update on the recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases; the study is active b…
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: COVID-19 VaccinE Response in Rheumatology Patients [Phase 4]
Phase 4 trial evaluating the COVID-19 vaccine response in patients with rheumatic diseases has completed, including rheumatoid arthritis, ps…
-
CLINICAL_TRIALS trial_result · 2025-01-13Clinical Trial Update: Vunakizumab in Adults with Spondyloarthritis [Phase 4]
Phase 4 clinical trial update for Vunakizumab in adults with spondyloarthritis; the study status is NOT_YET_RECRUITING.
-
CLINICAL_TRIALS trial_result · 2025-01-10Clinical Trial Update: Vaccination Against Herpes Zoster in Patients With Inflammatory Rheumatic Diseases [Phase 4]
Phase 4 clinical trial is currently enrolling by invitation to evaluate herpes zoster vaccination in patients with inflammatory rheumatic di…
-
CLINICAL_TRIALS trial_result · 2024-07-24Clinical Trial Update: Value of Whole-body SPECT-CT CzT-based Camera (VERITON-CT) in the Assessment of Chronic Inflammatory Rheumatism With Axial Involvement
A completed clinical trial evaluating the VERITON-CT whole-body CzT-based SPECT-CT camera for assessing chronic inflammatory rheumatism with…
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Baricitinib in the Treatment of Refractory Axial Spondyloarthritis Patients: A Comparison With Tofacitinib [Phase 2]
A Phase 2 trial comparing baricitinib to tofacitinib for refractory axial spondyloarthritis, with status currently UNKNOWN.
-
CLINICAL_TRIALS trial_result · 2022-11-21Clinical Trial Update: Study of Jitongning Tablet to Treat Spondyloarthritis [Phase 2]
Phase 2 trial of Jitongning Tablet for spondyloarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-28Clinical Trial Update: A Study of Ixekizumab (LY2439821) in Chinese Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 clinical trial of ixekizumab in Chinese participants with radiographic axial spondyloarthritis has completed and results were posted…
-
CLINICAL_TRIALS trial_result · 2022-05-04Clinical Trial Update: Golimumab (MK-8259 / SCH900259) Treatment Withdrawal in Participants With Non-radiographic Axial Spondyloarthritis (GO-BACK) (MK-8259-038) [Phase 4]
Phase 4 trial update on withdrawal of golimumab (MK-8259 / SCH900259) in participants with non-radiographic axial spondyloarthritis, complet…
-
CLINICAL_TRIALS trial_result · 2021-10-25Clinical Trial Update: Imaging Biomarkers in Crohn's Associated Spondyloarthritis
Completed clinical trial evaluating imaging biomarkers in Crohn's disease-associated spondyloarthritis; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: Enthesitis Assessment Before and After Anti-Tumor Necrosis Factor Treatment in Spondyloarthritis [Phase 4]
Phase 4 trial update evaluating enthesitis assessment before and after anti-TNF treatment in spondyloarthritis.
-
CLINICAL_TRIALS trial_result · 2020-06-16Clinical Trial Update: Etanercept Withdrawal And Retreament Study In Subjects With Nr-ax SpA [Phase 4]
Phase 4 trial update on withdrawal and re-treatment with etanercept in Nr-axial spondyloarthritis (nr-axial SpA) completed with results post…
-
CLINICAL_TRIALS trial_result · 2020-02-19Clinical Trial Update: SKIPPAIN - Speed of Onset of SecuKinumab-Induced Relief From Pain in Patients With AxIal SpoNdyloarthritis [Phase 3]
Phase 3 trial update on SecuKinumab for speed of onset of relief in axial spondyloarthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2019-12-19Clinical Trial Update: Treatment of Axial Spondyloarthritis by Recombinant Human Tumor Necrosis Factor-α Receptor Ⅱ IgG Fc Fusion Protein [Phase 4]
Phase 4 clinical trial update on a recombinant TNF-α receptor fusion protein for axial spondyloarthritis shows completed status.
-
CLINICAL_TRIALS trial_result · 2019-12-13Clinical Trial Update: 99mTc-rhAnnexin V-128 in Diagnosis of Spondyloarthritis [Phase 2]
A Phase 2 clinical trial evaluating 99mTc-rhAnnexin V-128 for diagnosing spondyloarthritis was terminated with results posted in 2019.
-
CLINICAL_TRIALS trial_result · 2019-11-19Clinical Trial Update: A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 trial update for ixekizumab in biologic DMARD-naive participants with radiographic axial spondyloarthritis has completed; results po…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: A Study of Ixekizumab (LY2439821) in TNF Inhibitor Experienced Participants With Radiographic Axial Spondyloarthritis [Phase 3]
Phase 3 trial evaluating ixekizumab in TNF inhibitor–experienced participants with radiographic axial spondyloarthritis has completed, with …
-
CLINICAL_TRIALS trial_result · 2019-09-26Clinical Trial Update: Treat-to-target Strategy in Ankylosing Spondylitis Using Etanercept and Conventional Synthetic DMARDs [Phase 4]
A phase 4 clinical trial evaluating a treat-to-target strategy in ankylosing spondylitis using etanercept and conventional synthetic DMARDs.